This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Elbein, S. C. Articles by Scroggin, E. Search for Related Content PubMed PubMed Citation Articles by Elbein, S. C. Articles by Scroggin, E.

Linkage and Molecular Scanning Analyses of MODY3/Hepatocyte Nuclear Factor-1 Gene in Typical Familial Type 2 Diabetes: Evidence for Novel Mutations in Exons 8 and 10¹

Division of Endocrinology and Metabolism, John L. McClellan Memorial Veterans Hospital, and University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205

Address all correspondence and requests for reprints to: Steven C. Elbein, M.D., Endocrinology 111J/LR, John L. McClellan Memorial Veterans Hospital, 4300 West 7th Street, Little Rock, Arkansas 72205. E-mail: sce{at}nidgene1.uams.edu

Mutations of the hepatocyte nuclear factor-1 (HNF1) gene are an important cause of autosomal dominant diabetes with onset before age 25 yr [maturity-onset diabetes of the young (MODY)], and some regions of the HNF1 gene appear to be hot spots for mutations. To evaluate the role of HNF1 in the more common familial type 2 diabetes, we studied 62 families of Northern European origin by linkage analysis and molecular screening. Linkage was rejected under dominant models consistent with either late-onset type 2 diabetes or early-onset dominant diabetes. We used single strand conformation polymorphism analysis to screen 53 diabetic members of 36 families who reported diabetes diagnosed before age 40 yr, 9 members of 2 Utah families with typical MODY, and 24 additional members of families with possible linkage. One MODY family showed the previously reported frameshift mutation (P291fsinsC) in exon 4. Among the individuals with more typical type 2 diabetes, we identified the previously reported common polymorphisms, a new intronic polymorphism, and 3 common amino acid variants. We also identified 2 novel missense mutations that segregated with type 2 diabetes in 1 family each: lysine for glutamic acid substitution at codon 619 in exon 10 (E619K), and an arginine for threonine substitution at codon 537 in exon 8 (R537T) in a second family. The exon 8 mutation showed relatively low penetrance, and the role in this family remains uncertain. No coding mutations were identified in the family members screened on the basis of linkage but without early-onset diabetes. Although HNF1 mutations are not a common cause of familial type 2 diabetes, they may account for 5% of families in which at least 1 member has onset of type 2 diabetes before age 40 yr. Incomplete penetrance and a high sporadic frequency make linkage an inefficient screening tool.

This article has been cited by other articles:

				H. S. Freitas, G. F. Anhe, K. F. S. Melo, M. M. Okamoto, M. Oliveira-Souza, S. Bordin, and U. F. Machado Na+-Glucose Transporter-2 Messenger Ribonucleic Acid Expression in Kidney of Diabetic Rats Correlates with Glycemic Levels: Involvement of Hepatocyte Nuclear Factor-1{alpha} Expression and Activity Endocrinology, February 1, 2008; 149(2): 717 - 724. [Abstract] [Full Text] [PDF]

				S. C. Elbein and M. A. Karim Does the Aspartic Acid to Asparagine Substitution at Position 76 in the Pancreas Duodenum Homeobox Gene (PDX1) Cause Late-Onset Type 2 Diabetes? Diabetes Care, August 1, 2004; 27(8): 1968 - 1973. [Abstract] [Full Text] [PDF]

				S. K. Das, S. J. Hasstedt, Z. Zhang, and S. C. Elbein Linkage and Association Mapping of a Chromosome 1q21-q24 Type 2 Diabetes Susceptibility Locus in Northern European Caucasians Diabetes, February 1, 2004; 53(2): 492 - 499. [Abstract] [Full Text]

				S. C. Elbein Perspective: The Search for Genes for Type 2 Diabetes in the Post-Genome Era Endocrinology, June 1, 2002; 143(6): 2012 - 2018. [Abstract] [Full Text] [PDF]

				C. A. Aguilar-Salinas, E. Reyes-RodrÍguez, Ma. L. Ordóñez-Sánchez, M. A. Torres, S. Ramírez-Jiménez, A. Domínguez-López, J. R. MartÍnez-Francois, Ma. L. Velasco-Pérez, M. Alpizar, E. GarcÍa-GarcÍa, et al. Early-Onset Type 2 Diabetes: Metabolic and Genetic Characterization in the Mexican Population J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 220 - 226. [Abstract] [Full Text]

				K. C. Chiu, L.-M. Chuang, J. M. Ryu, G. P. Tsai, and M. F. Saad The I27L Amino Acid Polymorphism of Hepatic Nuclear Factor-1{alpha} Is Associated with Insulin Resistance J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2178 - 2183. [Abstract] [Full Text]

				Q.-X. Hua, M. Zhao, N. Narayana, S. H. Nakagawa, W. Jia, and M. A. Weiss Diabetes-associated mutations in a beta -cell transcription factor destabilize an antiparallel "mini-zipper" in a dimerization interface PNAS, February 29, 2000; 97(5): 1999 - 2004. [Abstract] [Full Text] [PDF]